The telehealth-consultation platform posted an increase in profit and revenue for the second quarter on growth in subscribers ...

Hims & Hers Health, a telehealth platform that sells knock offs of popular weight loss drugs, sank in after-hours trading ...

Hims & Hers ...

公司当季营收同比激增73%至5.448亿美元，但低于5.52亿美元的市场预期。调整后每股收益0.17美元（预期0.15美元），调整后EBITDA达8200万美元（去年同期3930万美元），实现翻倍增长。

Hims Hers Health Inc.公布了2025年第二季度财报，每股收益 (EPS)表现亮眼。公司报告的每股收益为$0.17，超过预期的$0.15，惊喜度达13.33%。然而，收入略低于预期，为$544.8百万，而预测为$549.87百万。尽管如此，该股票在市场上反应积极，常规交易时段上涨1.31%，盘后交易进一步上涨1.49%。

英为财情Investing.com - Hims Hers Health (NYSE: HIMS )星期一发布了第二季度的财报，数据显示，公司营收逊于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$0.17，总营收为$544.8M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$549.87M，每股收益为$0.15.

Hims & Hers Health stock missed on earnings last night. The company grew sales 73% and profits tripled, but Wall Street ...

Hims & Hers Health (HIMS) stock falls after reporting lower Q2 revenues. Analysts caution about near-term challenges, ...

在最新的市场动态中，Hims & Hers Health (HIMS.US) ...

Hims stock crashed late Monday after the obesity kingpin lagged Wall Street's second-quarter sales forecasts, though profit ...

(Reuters) -Shares of telehealth firm Hims & Hers fell as much as 5% on Tuesday after the company reported weaker-than-expected second-quarter revenue, hurt by a loss of subscribers in its weight-loss ...